 LEXINGTON, Mass.--BUSINESS WIRE--Frequency Therapeutics, Inc. Nasdaq: FREQ, a clinical-stage regenerative medicine company focused on developing therapeutics to activate a persons innate regenerative potential to restore function, today announced that Chief Scientific Officer Dr. Christopher Loose and Vice President of Discovery Biology Dr. Sanjay Magavi will participate in a fireside presentation at the B. Riley Securities Neuro Ophthalmology Conference on April 28, 2022 at 3:30 pm 